Results 81 to 90 of about 26,051 (185)

CARDIAC AMYLOIDOSIS [PDF]

Heart, 1956
R, BENSON, J F, SMITH
openaire   +2 more sources

Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management

European Journal of Haematology, Volume 117, Issue 5, Page 1159-1167, November 2026.
ABSTRACT Light chain monoclonal gammopathy of undetermined significance (LC‐MGUS) is defined by an abnormal serum free light chain ratio and elevated involved light chain in the absence of a detectable immunoglobulin heavy chain on immunofixation and of end‐organ damage attributable to a plasma cell disorder.
Sigurður Yngvi Kristinsson, Thórir Einarsson Long, Sigrún Thorsteinsdóttir   +2 more
wiley   +1 more source

Cardiovascular-Related Mortality and Hospitalizations in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: A Post Hoc Analysis of the Phase 3 ATTR-ACT and Long-Term Extension

Cardiology and Therapy
Introduction Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are at high risk of cardiovascular (CV)-related hospitalizations (CVH), which are associated with higher mortality.
Thibaud Damy, Ronald Witteles, Francesco Cappelli, Ronnie Wang, Martha Grogan   +4 more
doaj   +1 more source

Cardiac Amyloidosis [PDF]

Circulation, 2012
C Cristina, Quarta, Jenna L, Kruger, Rodney H, Falk   +2 more
openaire   +2 more sources

Serum amyloidosis: a cardiac amyloidosis

European Heart Journal - Cardiovascular Imaging, 2023
Jeremy A Slivnick, Varun Subashchandran, Nitasha Sarswat, Amit R Patel   +3 more
openaire   +2 more sources

Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study

Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge, Maria E. Sundaram, Huong Q. Nguyen, Jennifer P. King, Elisha Stefanski, Andrew G. Allmon, Jean‐Yves Pirçon, Pouya Saeedi   +7 more
wiley   +1 more source

Microvascular Obstruction in Cardiac Amyloidosis

European Journal of Heart Failure
Aims Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis.
Netti L., Ioannou A., Martinez-Naharro A., Razvi Y., Porcari A., Venneri L., Maestrini V., Knight D., Virsinskaite R., Rauf M. U., Kotecha T., Patel R. K., Wechelakar A., Lachmann H., Kellman P., Manisty C., Moon J., Hawkins P. N., Gillmore J. D., Fontana M.   +19 more
openaire   +3 more sources

Beyond the Heart: Hepatic Extracellular Volume Assessment in Patients With Cardiovascular Disease

Journal of Magnetic Resonance Imaging, Volume 64, Issue 5, Page 1472-1473, November 2026.
Kenichiro Suwa, Yuichiro Maekawa
wiley   +1 more source

AL Amyloidosis Presenting as Heart Failure: A Case Report and Review of Literature

Indian Journal of Clinical Cardiology
Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed cause of heart failure, and it is associated with significant morbidity and mortality.
Kumar R., Grover T., Garg A., Agarwal P.K.   +3 more
doaj   +1 more source

Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report

International Journal of Emergency Medicine
Introduction Cardiac amyloidosis is a rarely reported and potentially fatal variant of the systemic disease. Its early diagnosis could potentially lead to significantly improved clinical outcomes.
Nahid Senobari, Roozbeh Nazari, Pouya Ebrahimi, Hamidreza Soleimani, Maryam Taheri, Kaveh Hosseini, Homa Taheri, Robert J. Siegel   +7 more
doaj   +1 more source